Published in PLoS One on September 08, 2016
Statins for Acutely Injured Lungs From Sepsis (SAILS) | NCT00979121
Drug Study of Albuterol to Treat Acute Lung Injury (ALTA) | NCT00434993
Viral-Related Neutrophil Response and Condition Severity in People With ARDS | NCT00548795
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet (2001) 63.36
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
The acute respiratory distress syndrome. N Engl J Med (2000) 25.38
Incidence and outcomes of acute lung injury. N Engl J Med (2005) 21.56
A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 12.86
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Interferon-inducible antiviral effectors. Nat Rev Immunol (2008) 9.68
Type I interferons in host defense. Immunity (2006) 7.32
Innate recognition of viruses. Immunity (2007) 6.21
Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev (2006) 5.92
The acute respiratory distress syndrome. J Clin Invest (2012) 5.61
Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. Am J Respir Crit Care Med (2011) 5.24
Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA (2011) 5.08
Granules of the human neutrophilic polymorphonuclear leukocyte. Blood (1997) 5.07
Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood (2006) 5.05
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol (1985) 5.02
Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med (1995) 4.68
Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA (2012) 4.67
Neutrophils and acute lung injury. Crit Care Med (2003) 4.56
Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe (2009) 4.55
Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med (2004) 4.34
Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA (2008) 4.19
Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis (2008) 3.92
Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med (2002) 3.87
Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis (2006) 3.74
Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med (2008) 3.67
Regulation of type I interferon responses. Nat Rev Immunol (2014) 3.60
Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med (2014) 3.39
Complications of viral influenza. Am J Med (2008) 3.28
The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA (1996) 3.09
Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J Exp Med (2004) 3.06
Expression profiling--best practices for data generation and interpretation in clinical trials. Nat Rev Genet (2004) 2.91
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med (1996) 2.81
The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study. Lancet Respir Med (2013) 2.80
Molecular mechanisms of endotoxin tolerance. J Endotoxin Res (2004) 2.60
Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979- 1996). Crit Care Med (2002) 2.52
Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med (2011) 2.39
Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J Virol (2002) 2.38
Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol (2007) 2.14
Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA (1995) 2.12
Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med (1999) 2.07
The association between body mass index and clinical outcomes in acute lung injury. Chest (2007) 1.96
The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Implications for the pathogenesis of lung infections. Am Rev Respir Dis (1991) 1.81
Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun (2006) 1.67
The influence of influenza virus infection on exogenous staphylococcal and endogenous murine bacterial infection of the bronchopulmonary tissues of mice. J Exp Med (1961) 1.57
G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J (2000) 1.53
Genetic polymorphisms and sepsis. Shock (2005) 1.50
Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J Exp Med (2010) 1.50
Emphysema lung tissue gene expression profiling. Am J Respir Cell Mol Biol (2004) 1.49
Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome. Ann Intern Med (2002) 1.49
A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J Biol Chem (2002) 1.47
Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Ann Rheum Dis (2008) 1.45
Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting. Chest (2000) 1.45
Recent advances in genetic predisposition to clinical acute lung injury. Am J Physiol Lung Cell Mol Physiol (2009) 1.34
MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis (1994) 1.29
Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit Care (2006) 1.23
Shifting the paradigm: host gene signatures for diagnosis of infectious diseases. Cell Host Microbe (2009) 1.22
Microarray analysis of lipopolysaccharide-treated human neutrophils. Am J Physiol Lung Cell Mol Physiol (2002) 1.13
Immune dysfunction and bacterial coinfections following influenza. J Immunol (2013) 1.10
Periodontitis associates with a type 1 IFN signature in peripheral blood neutrophils. J Immunol (2008) 1.08
Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. J Virol (2012) 1.06
Induction of type I interferon signaling determines the relative pathogenicity of Staphylococcus aureus strains. PLoS Pathog (2014) 1.06
HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury. Intensive Care Med (2007) 1.04
Attenuation of the type I interferon response in cells infected with human rhinovirus. Virology (2008) 1.04
The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury. Chest (2011) 1.02
Suppression of the interferon-mediated innate immune response by pseudorabies virus. J Virol (2006) 1.01
Interferon-stimulated genes and their role in controlling hepatitis C virus. J Hepatol (2013) 0.99
Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Respir Med (2007) 0.98
Cellular reprogramming by gram-positive bacterial components: a review. J Leukoc Biol (2006) 0.97
Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival. Crit Care Med (2000) 0.90
Subversion of innate host antiviral strategies by the hepatitis C virus. Arch Biochem Biophys (2007) 0.88
Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children. Pediatr Res (1997) 0.86
Neutrophil oxidative burst activation and the pattern of respiratory physiologic abnormalities in the fulminant post-traumatic adult respiratory distress syndrome. Circ Shock (1991) 0.85
Bacteria-specific neutrophil dysfunction associated with interferon-stimulated gene expression in the acute respiratory distress syndrome. PLoS One (2011) 0.84
Lipopolysaccharide stimulates p38-dependent induction of antiviral genes in neutrophils independently of paracrine factors. J Biol Chem (2003) 0.84
Reduced bactericidal activity against Staphylococcus aureus and Pseudomonas aeruginosa of blood neutrophils from patients with early adult respiratory distress syndrome. J Med Microbiol (2001) 0.81